Sands Capital Life Sciences Pulse Fund II, L.P.

Activist investor & 5%+ owner · SC 13D/13G filings

Total Filings

Stocks Covered

Latest Filing

Feb 13, 2026

Filings

Inhibikase Therapeutics, Inc.

SC 13G/A · Feb 13, 2026

10.8%

13.0M shares

Inhibikase Therapeutics, Inc.

SC 13G/A · Aug 13, 2025

14.7%

10.9M shares

Acrivon Therapeutics, Inc.

SC 13G/A · Aug 13, 2025

6.8%

2.1M shares

Inhibikase Therapeutics, Inc.

SC 13G · Oct 25, 2024

16.3%

10.9M shares

Acrivon Therapeutics, Inc.

SC 13G/A · Feb 13, 2024

7.4%

1.7M shares

Acrivon Therapeutics, Inc.

SC 13G/A · Feb 14, 2023

7.9%

1.7M shares

Acrivon Therapeutics, Inc.

SC 13G · Nov 25, 2022

7.9%

1.7M shares